MAT
46
12
SO
53
-4
AA
48
-12
HCA
44
-2
NEE
50
-5
ROST
63
12
SIG
52
3
CMA
61
5
NTAP
67
-3
R
71
4
MA
64
7
CA
38
6
XRAY
28
2
AAP
24
6
PRGO
39
3
UA
50
-9
TGT
22
2
GOOGL
40
-5
BK
74
2
HON
67
2
MAT
46
12
SO
53
-4
AA
48
-12
HCA
44
-2
NEE
50
-5
ROST
63
12
SIG
52
3
CMA
61
5
NTAP
67
-3
R
71
4
MA
64
7
CA
38
6
XRAY
28
2
AAP
24
6
PRGO
39
3
UA
50
-9
TGT
22
2
GOOGL
40
-5
BK
74
2
HON
67
2
Financhill
Back

Rocket Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
43

RCKT
Rocket Pharmaceuticals

Last Price:
14.09
Seasonality Move:
13.34%
Sell
48

APLS
Apellis Pharmaceuticals

Last Price:
30.76
Seasonality Move:
16.11%
Sell
43
Rocket Pharmaceuticals (RCKT) is a Sell

Is Rocket Pharmaceuticals a Buy, Sell or Hold?

  • The current Rocket Pharmaceuticals [RCKT] share price is $14.11. The Score for RCKT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $30.77. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCKT Stock Price Chart

What is Rocket Pharmaceuticals's stock price today?

  • The Rocket Pharmaceuticals share price today is $14.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $30.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RCKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.13 Sell
Relative Strength Index (14 RSI): 37.41 Sell
Chaikin Money Flow: 1084581 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.48 - 17.76) Sell
Bollinger Bands (100): (16.17 - 21.73) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 59.23 Buy
Chaikin Money Flow: 2322513 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.9 - 29.12) Buy
Bollinger Bands (100): (28.55 - 38.61) Sell

RCKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.9 Buy
20-day SMA: 15.79 Sell
50-day SMA: 17.17 Sell
200-day SMA: 21.87 Sell
8-day EMA: 14.06 Buy
20-day EMA: 15.3 Sell
50-day EMA: 16.83 Sell
200-day EMA: 20.2 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.97 Buy
20-day SMA: 28.22 Buy
50-day SMA: 29.11 Buy
200-day SMA: 42.36 Sell
8-day EMA: 28.48 Buy
20-day EMA: 28.34 Buy
50-day EMA: 29.88 Buy
200-day EMA: 39.46 Sell

Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.27 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.

Rocket Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):